Lapatinib Synthesis via Trifluoroacetyl Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for synthesizing Lapatinib, an active pharmaceutical ingredient used in treating advanced metastatic lung cancer, face challenges such as low productivity due to poorly soluble intermediates and issues related to waste disposal, particularly with stannane intermediates, leading to low overall molar yield.
Innovation Solution
A process involving deprotection and amine protection reactions of specific intermediates, using trifluoroacetyl as a protecting group, to synthesize Lapatinib, which allows for higher yields and avoids the isolation of intermediates, thereby improving atom economy and scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If stannane intermediates are used in the synthesis process, then the reaction can proceed, but waste disposal problems arise and overall molar yield decreases
Solution Approach 1:
The patent removes stannane intermediates from the synthesis pathway entirely, replacing them with alternative reagents that do not generate harmful waste. This extraction of the problematic substance eliminates the waste disposal issue while maintaining reaction efficiency and improving overall molar yield.
Solution Approach 2:
The patent changes the chemical parameters of the intermediate compounds by substituting stannane-based reagents with organoboron or other metal-free reagents. This parameter change in the chemical composition eliminates the harmful waste generation while preserving the synthetic utility and improving the overall yield of the process.
2Productivity
If intermediates with aldehyde function in free form are used, then the synthesis can proceed, but solubility is poor leading to low productivity
Solution Approach 1:
The patent applies preliminary protection to the aldehyde functional group in the intermediate compounds, converting them into more soluble forms before subsequent reactions. This preliminary action of protecting the aldehyde group improves the solubility and handling of intermediates, thereby enhancing productivity without compromising the final product quality.
3Ease of manufacture
If multiple isolation steps of intermediates are performed, then purification can be achieved, but process complexity increases and atom economy decreases
Solution Approach 1:
The patent merges multiple isolation and purification steps into a streamlined sequence, combining operations that can be performed in one pot or with minimal intervention. This merging reduces the number of discrete steps, lowers process complexity, and improves atom economy while still achieving the necessary purification quality for pharmaceutical standards.
Data Source
AI summary
The present invention refers to a new efficient process for the synthesis of the active pharmaceutical ingredient Lapatinib and salts thereof.In particular, the present synthesis is carried out employing new intermediates in which the amine function is protected by a group cleavable in basic milieu that provides a higher overall yield of the synthesis process.